Bristol Myers Squibb Co. is a pharmaceutical organization that was founded in 1887 and is headquartered in New York, United States.

Boehringer Ingelheim GmbH is a pharmaceutical organization that was founded in 1885 and is headquartered in Rheinland-Pfalz, Germany.

Biogen, Inc. is a biotechnology company based in Cambridge, Massachusetts, USA, specializing in the development of neurological diseases, autoimmune diseases, and cancer drugs.

BeiGene Ltd. is a global biotechnology company founded in 2010 and is one of China's leading innovative pharmaceutical companies.

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is Germany's largest industrial group.

Arvinas, Inc. is a biopharmaceutical company that was founded in 2013 and is based in Connecticut, United States.

Argenx SE is a biopharmaceutical company that was founded in 2008 and is based in Zuid-Holland, Netherlands.

Founded in 1994, Exelixis, Inc. is a biotechnology company in California focused on the anti-tumor field that has commercialized new drug products.

Amgen Inc. is a biotechnology company dedicated to providing biological therapeutics to patients with serious diseases by discovering, developing, manufacturing, and delivering innovative human therapies.

Alkermes Plc is a biopharmaceutical company focused on central nervous system (CNS) disorders such as schizophrenia, depression, addiction, and multiple sclerosis.

AbbVie, Inc. is a pharmaceutical organization that was founded in 2013 and is based in Illinois, United States.

Merck exercised its option to co-develop and commercialize mRNA-4157/V940 with Moderna for adjuvant treatment in high-risk melanoma patients.